Clinical case of severe immune thrombocytopenia during pregnancy
DOI:
https://doi.org/10.15574/PP.2023.94.142Keywords:
immune thrombocytopenia, pregnancy, severe thrombocytopenia, eltrombopag, recombinant human thrombopoietinAbstract
Immune thrombocytopenia (ITP) is one of the most common causes of thrombocytopenia (TP) in pregnancy and is the main cause of severe TP among pregnant women. Autoimmune pathogenesis determines the danger of hemorrhagic complications both for the pregnant and for the fetus and newborn. Differential diagnosis between gestational and immune thrombocytopenia is necessary, as this determines further tactics. The goal of ITP treatment is to achieve a safe level of platelets according to the gestational age and clinical situation. For treatment, different lines of therapy are used alternately with step-by-step control of effectiveness.
Purpose - to analyze the worldwide and personal experience of pregnancy management in severe ITP refractory to treatment.
We present a case of pregnancy management and delivery with a severe immune thrombocytopenia, diagnosed at 25 weeks of pregnancy with hemorrhagic syndrome, unresponsive to treatment. All pharmacological tools were used. Delivery by caesarean section with appropriate preoperative and intraoperative transfusion preparation. Recombinant human thrombopoietin was used in the postoperative period. The newborn has thrombocytopenia without hemorrhagic syndrome.
Conclusions. Correct diagnosis of conditions accompanied by thrombocytopenia during pregnancy determines the correct and effective treatment tactics.
Pregnancy and childbirth in women with severe thrombocytopenia belong to the group of extremely high risk. Antenatal management and delivery of such pregnant women should be carried out by a multidisciplinary team with the participation of a hematologist, a specialist in internal medicine, under careful control of laboratory indicators and clinical changes, with control of the fetal antenatal condition. It is necessary to control the platelet level of the newborn in the postnatal period.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Alberico S, Bogatti P, Marchesan E, Cervi G, Toffoletti F. (1992). Report of a case of autoimmune thrombocytopenic purpura in pregnancy. Minerva Ginecol. 44 (7-8): 387-393.
American Society of Hematology. (2013). Clinical Practice Guidelines on Thrombocytopenia in Pregnancy. Thrombocytopenia - pocket-Guide. URL: https://www.academia.edu/17649565/2013_Thrombocytopenia_Pocket_Guide.
Amorim JG, Abecasis MR, Rodrigues FM. (2018). Refractory Severe Thrombocytopenia during Pregnancy: How to Manage. Rev Bras Ginecol Obstet. 40; 12: 803-807. https://doi.org/10.1055/s-0038-1675186; PMid:30536273
Bernal-Macías S, Fino-Velásquez L, Vargas-Barato F, Guerra-Galue L, Reyes-Beltrán B, Rojas-Villarraga A. (2015). Refractory Immunological Thrombocytopenia Purpura and Splenectomy in Pregnancy. Case Reports Immunol: 216362. https://doi.org/10.1155/2015/216362; PMid:26798527 PMCid:PMC4698536
Care A, Pavord S, Knight M, Alfirevic Z. (2018). Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study. BJOG. 125 (5): 604-612. https://doi.org/10.1111/1471-0528.14697; PMid:28432736
Donohoe F, Higgins M, Higgins S, McAuliffe F, Murphy K. (2019). Rituximab - A novel therapy for severe ITP in pregnancy: A case report. Obstet Med. 12 (4): 196-198. https://doi.org/10.1177/1753495X18778489; PMid:31853261 PMCid:PMC6909297
Fadiloglu E, Unal C, Tanacan A, Portakal O, Beksac MS. (2020). 5 Yearsʼ Experience of a Tertiary Center with Thrombocytopenic Pregnancies: Gestational Thrombocytopenia, Idiopathic Thrombocytopenic Purpura and Hypertensive Disorders of Pregnancy Geburtsh Frauenheilk. 80: 76-83. https://doi.org/10.1055/a-0865-4442; PMid:31949322 PMCid:PMC6957351
Ferreira IJ, Sousa F, Vasco EM, Areia ALFA, Moura JPAS. (2018). Severe immune thrombocytopenia in pregnancy treated with Eltrombopag - A case report. Journal of Gynecology Obstetrics and Human Reproduction. 47 (8): 405-408. https://doi.org/10.1016/j.jogoh.2018.06.010; PMid:29981476
Fujimura K, Harada Y, Fujimoto T, Kuramoto A, Ikeda Y, Akatsuka J, Dan K et al. (2002). Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol. 75 (4): 426-433. https://doi.org/10.1007/BF02982137; PMid:12041677
Gernsheimer T, James AH, Stasi R. (2013). How I treat thrombocytopenia in pregnancy. Blood. 121; 1: 38-47. https://doi.org/10.1182/blood-2012-08-448944; PMid:23149846
Jamal S, Goel N, Mehta A, Ahuja M. (2017). Recurrent severe gestational thrombocytopenia in pregnancy: a case report. Int J Adv Med. 4: 1702-1705. https://doi.org/10.18203/2349-3933.ijam20175196
Kong Z, Qin P, Xiao S, Zhou H, Li H, Yang R et al. (2017). A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy. Blood. 31; 130 (9): 1097-1103. https://doi.org/10.1182/blood-2017-01-761262; PMid:28630121
Orisaka M, Shukunami K, Orisaka S, Goto K, Yoshida Y, Kotsuji F. (2005). Combination therapy for pregnant with severe refractory ITP. European Journal of Obstetrics & Gynecology and Reproductive Biology. 121: 119-120. https://doi.org/10.1016/j.ejogrb.2004.12.013; PMid:15989989
Pavord S, Hunt B. (2010). The Obstetric Hematology Manual. Cambridge University Press. https://doi.org/10.1017/CBO9780511676451
Provan D, Arnold DM, Bussel JB, Chong BH et al. (2019). Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 3; 22: 3780-3817. https://doi.org/10.1182/bloodadvances.2019000812; PMid:31770441 PMCid:PMC6880896
Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S. (2016). A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. Asian J Transfus Sci. 10 (2): 155-158. https://doi.org/10.4103/0973-6247.177204; PMid:27605856 PMCid:PMC4993088
Ramadan MK, Hubeich M, Itani SE, Mogharbil A. (2016). Severe Gestational Thrombocytopenia: A Case Report and Brief Review of the Literature. Journal of Hematology. 5; 4: 142-150. https://doi.org/10.14740/jh308w
Wang D, Liang M, Wang S. (2010). Clinical analysis of pregnancy complicated with severe thrombocytopenia. Zhonghua Fu Chan Ke Za Zhi. 45 (6): 401-405.
Yavaşoğlu I, Turgutkaya A. (2020). Pregnancy and immune thrombocytopenia: New trends. J Turk Ger Gynecol Assoc. 21 (2): 136-137. https://doi.org/10.4274/jtgga.galenos.2019.2019.0142; PMid:31927816 PMCid:PMC7294828
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ukrainian Journal of Perinatology and Pediatrics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
